Glycosylphosphatidylinositol (GPI) anchor proteins, commonly occurring on cell membranes and expressed on EV membranes, can bind to anti- EGFR nanobodies, enabling the targeting of tumor cells overexpressing EGFR[103]. Here, EGFR is linked to neoplasm.